Avid Bioservices Inc (CDMO)

[entdoc]

dawginlife, agree that FDA will act correctly on this as they usually do. If the FDA overshoots it seems to be in the direction of supporting new avowed cures rather than the opposite. The FDA wants to move the ball forward also, and we all know the side-effect profile trumps all but efficacy. Even slight efficacy indications in "far-gone" cases would imply a responsibility to allow continued human trials, and wider use of Bavi. That said, it would not be surprised to see some...uhh...damping or tamping down of the somewhat exuberant numbers reported. If it's too good to be true... Garnick had never seen anything like it...Gazillions! Oversell. REpeat...if you've been in the eye of a new storm-force for good, and for making money, you understand the aggressive forces brought to bear here.